Following Lifestyle Recommendations Reduces Risk of Cancer Death (05-15-2013)

People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying from several diseases and specifically, a 20 percent... Continue Reading

Second Large Study Confirms Oncotype DX Can Predict Recurrence in Stage 2 Colon Cancer (04-22-2013)

Results from the large CALGB 9581 clinical validation study of the Oncotype DX® colon cancer test confirm that Recurrence Score® (RS) results improve the ability to differentiate high recurrence risk disease from low recurrence risk disease, beyond... Continue Reading

Combo Treatment Effective in Elderly Patients with Metastatic Colorectal Cancer (03-6-2013)

Combination therapy with Avastin® (bevacizumab) and Xeloda® (capecitabine) may be an optimal first-line treatment for treatment-naïve older patients with metastatic colorectal cancer, according to the results of a study presented at the 2013 Gastrointestinal... Continue Reading

Neulasta Significantly Reduces Febrile Neutropenia Among Colorectal Cancer Patients Receiving Chemotherapy Plus Avasatin (02-25-2013)

Neulasta® (pegfilgrastim) significantly reduced the incidence of grade 3/4 febrile neutropenia among patients with locally advanced or metastatic colorectal cancer who received chemotherapy with FOLFOX or FOLFIRI followed by Avastin® (bevacizumab),... Continue Reading

Oncotype DX in Colon Cancer May Reduce Medical Costs and Improve Patient Wellbeing (02-20-2013)

The results of two studies evaluating Oncotype DX were presented at the 2013 Gastrointestinal Cancers Symposium in San Francisco and the data indicated that the colon cancer test may reduce medical costs, improve patient wellbeing, and change treatment... Continue Reading

Cancer Deaths on the Decline (02-11-2013)

Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National Cancer Institute. What’s more—cancer incidence... Continue Reading

Patients with Advanced Cancer May Have Inaccurate Expectations of Chemotherapy (11-7-2012)

Patients with advanced, incurable cancer may have the inaccurate belief that chemotherapy can cure their cancer, according to the results of a study published in the New England Journal of Medicine—and such misconceptions could compromise their ability... Continue Reading

Aspirin May Prolong Life in PIK3CA-Mutated Colorectal Cancers (11-6-2012)

Daily aspirin use improves survival among patients with mutated-PIK3CA colorectal cancer, according to the results of a study published in the New England Journal of Medicine. Colorectal cancer remains the second leading cause of cancer-related death... Continue Reading

Universal Tumor Testing to Identify Lynch Syndrome (10-30-2012)

Universal tumor MMR testing among patients with colorectal cancer may have a greater sensitivity for identifying Lynch syndrome than other screening strategies, according to the results of a study published in the Journal of the American Medical Association. Lynch... Continue Reading

B Vitamins Do Not Appear to Affect Colorectal Cancer Risk (10-22-2012)

A combination supplement of folic acid, vitamin B6 and vitamin B12 did not statistically significantly increase or decrease the risk of colorectal cancer in older women, according to the results of a study published in the Journal of the National Cancer... Continue Reading

Zaltrap Improves Survival in Metastatic Colorectal Cancer (10-16-2012)

The addition of Zaltrap® (ziv-aflibercept) to the FOLFIRI chemotherapy regimen improved overall survival in patients with metastatic colorectal cancer who were previously treated with Eloxatin® (oxaliplatin), according to the results of a phase III... Continue Reading

New Colonoscopy Surveillance Guidelines (10-10-2012)

The U.S. Multi-Society Task Force on Colorectal Cancer has released a consensus update regarding colonoscopy surveillance—and the guidelines indicate that average-risk patients who have a clean colonoscopy can wait 10 years between exams. Colorectal... Continue Reading